Works matching IS 00093157 AND DT 2015 AND VI 60 AND IP 3

Results: 12

Front & Back Matter.

Published in:: Chemotherapy (0009-3157), 2015, v. 60, n. 3, p. X, doi. 10.1159/000430778
Publication type:: Article

Long-Term Everolimus Treatment of Patients with Pancreatic Neuroendocrine Tumors.

Published in:

Chemotherapy (0009-3157), 2015, v. 60, n. 3, p. 143, doi. 10.1159/000369780

By:

Wolin, Edward M.

Publication type:

Article

In vitro Susceptibility of Tigecycline against Multidrug-Resistant Gram-Negative Strains: Etest versus Agar Dilution.

Published in:

Chemotherapy (0009-3157), 2015, v. 60, n. 3, p. 151, doi. 10.1159/000375440

By:

Özkök, Sezen;
Togan, Turhan;
Yesilkaya, Ayşegül;
Timurkaynak, Funda;
Azap, Özlem Kurt;
Arslan, Hande

Publication type:

Article

The Effects of the F-Actin Inhibitor Latrunculin A on the Pathogenic Yeast Cryptococcus neoformans.

Published in:

Chemotherapy (0009-3157), 2015, v. 60, n. 3, p. 185, doi. 10.1159/000377619

By:

Kopecká, Marie;
Yamaguchi, Masashi;
Kawamoto, Susumu

Publication type:

Article

Obesity and the Use of Antibiotics and Probiotics in Rats.

Published in:

Chemotherapy (0009-3157), 2015, v. 60, n. 3, p. 162, doi. 10.1159/000371737

By:

de Sá Del Fiol, Fernando;
Tardelli Ferreira, Alessandra Cristina Marciano;
Marciano, Jorge José;
Marques, Maria Claudia;
SantʼAna, Luciane Lopes

Publication type:

Article

Risk Factors for Cytarabine-Induced Cutaneous Toxicity in Patients with Haematological Malignancies.

Published in:

Chemotherapy (0009-3157), 2015, v. 60, n. 3, p. 168, doi. 10.1159/000371839

By:

Morio, Kayoko;
Mizuki, Masao;
Sozu, Takashi;
Uejima, Etsuko

Publication type:

Article

French Nationwide Cohort Temporary Utilization Authorization Survey of GranuPAS® in MDR-TB Patients.

Published in:

Chemotherapy (0009-3157), 2015, v. 60, n. 3, p. 174, doi. 10.1159/000371869

By:

Kibleur, Yves;
Veziris, Nicolas

Publication type:

Article

Phase I/II Study of Amrubicin and Nedaplatin in Patients with Untreated, Advanced, Non-Small Cell Lung Cancer.

Published in:

Chemotherapy (0009-3157), 2015, v. 60, n. 3, p. 180, doi. 10.1159/000371870

By:

Ogawara, Daiki;
Nakamura, Yoichi;
Fukuda, Minoru;
Nakatomi, Katsumi;
Yamaguchi, Hiroyuki;
Motoshima, Kohei;
Mizoguchi, Kosuke;
Nakano, Hirofumi;
Takemoto, Shinnosuke;
Gyotoku, Hiroshi;
Nagashima, Seiji;
Kohno, Shigeru

Publication type:

Article

Antibacterial Activity of Fosfomycin against Uropathogens.

Published in:

Chemotherapy (0009-3157), 2015, v. 60, n. 3, p. 157, doi. 10.1159/000371734

By:

Sun, Fengjun;
Chen, Sheng;
Qiu, Xuewen;
Sun, Yixuan;
Feng, Wei;
Chen, Jianhong;
Xia, Peiyuan

Publication type:

Article

Full-Dose Gemcitabine Is a More Effective Chemotherapeutic Agent Than 5-Fluorouracil for Concurrent Chemoradiotherapy as First-Line Treatment in Locally Advanced Pancreatic Cancer.

Published in:

Chemotherapy (0009-3157), 2015, v. 60, n. 3, p. 191, doi. 10.1159/000375402

By:

Kang, Huapyong;
Chang, Jee Suk;
Oh, Tak Geun;
Chung, Moon Jae;
Park, Jeong Youp;
Park, Seung Woo;
Seong, Jinsil;
Song, Si Young;
Chung, Jae Bok;
Bang, Seungmin

Publication type:

Article

ε-Caprolactone Is Not a 50-kDa Molecule when Applied in Micro-Chambered Beads.

Published in:

Chemotherapy (0009-3157), 2015, v. 60, n. 3, p. 200, doi. 10.1159/000374104

By:

Draenert, Florian

Publication type:

Article

Overall Response to First-Line Tyrosine Kinase Inhibitor and Second-Line Chemotherapy Is Predictive of Survival Outcome in Epidermal Growth Factor Receptor-Mutated Adenocarcinoma.

Published in:

Chemotherapy (0009-3157), 2015, v. 60, n. 3, p. 201, doi. 10.1159/000371735

By:

Kuo, Scott Chih-Hsi;
Hsu, Ping-Chih;
Chen, Chih-Hung;
Yu, Chih-Teng;
Wang, Chih-Liang;
Chung, Fu-Tsai;
Lin, Shu-Min;
Lo, Yu-Lun;
Chen, Tse-Ching;
Liu, Chien-Ying;
Yang, Cheng-Ta

Publication type:

Article